Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $FAF.V) (TSXV: $OGI.V) (NASDAQ: $OGI) (TSX: $TGOD.TO) (TSX: $WEED.TO) (NYSE: $CGC)
Delta, Kelowna, BC –June 20, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/06201FAF-OGI-TGOD-WEED-CGC.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we are looking at a few early announcements.
The Canadian Cancer Society (CCS) is calling for immediate government action to address a significant and troubling increase in youth vaping in Canada. The increase in rates was revealed in a new study published in the British Medical Journal.
The study, led by Professor David Hammond of the University of Waterloo, found that among those 16-19 years old, vaping increased by a stunning 74% from 2017 to 2018, from 8.4% to 14.6%. The study was conducted in August/September 2017 and again in August/September 2018.
The study presents the first data since the major tobacco companies launched and heavily advertised their own e-cigarette brands in Canada following the May 2018 adoption of Bill S-5 which legalized e-cigarettes with nicotine. The study results are consistent with indications from across Canada of high schools struggling to respond to a rapid increase in youth vaping.
Evidence indicates that youth who use e-cigarettes with nicotine may become addicted and are at increased risk of becoming smokers.
The study also found that cigarette smoking among 16-19 year-olds in the same 2017 to 2018 time period increased by 45%, from 10.7% to 15.5%. Prior surveys up to and including 2017 had shown a continuing decline in youth smoking. However, these concerning results indicate that youth smoking may now be increasing.
"E-cigarettes are supposed to be for adult smokers who have been unable to quit," says Rob Cunningham, Senior Policy Analyst, CCS. "But the results of this new study regarding youth trends are of tremendous concern. Given the progress that has been made to reduce youth smoking, we must avoid a new generation of teenagers becoming addicted to nicotine through vaping products."
CCS urges provinces to increase the minimum age to 21 for the sale of both tobacco and vaping products, as 16 US states have already done. Provinces should also prohibit the sale of flavoured vaping products except in adult-only specialty vape shops. Alberta and Saskatchewan, the only provinces without legislation on vaping products, should immediately adopt comprehensive legislation. Ontario should ban vaping product advertising in convenience stores and other retailers, as seven other provinces have done.
CCS recommends that the federal government move quickly to adopt regulations restricting the advertising of vaping products, ensuring regulations are at least as restrictive as advertising for cannabis, including medical cannabis. The federal government should also adopt restrictions on the use of flavours in vaping products, along with other regulatory measures.
Fire & Flower Holdings Corp. and its wholly-owned subsidiary Fire & Flower Inc. (TSXV: FAF), today announced that it has received an additional licence from the Alberta Gaming, Liquor and Cannabis Commission (the "AGLC") to open its second licensed cannabis retail store in Calgary, Alberta.
The store will be located at 7108 MacLeod Trail, Calgary, Alberta and is the 19th Fire & Flower branded, licenced store location in the Company's retail network. This announcement follows Fire & Flower's previous news release on May 31, 2019 announcing the Company' near-term store rollout schedule.
"Our team is excited to open a second licensed cannabis retail store in the major market of Calgary and we look forward to welcoming Calgarians into our new location," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "Fire & Flower had built out this location in anticipation of the issuance of additional cannabis retail licences in the province of Alberta. Receiving our licence to operate this store validates our strategy of building locations in advance and creates a clear path to rapidly opening new markets."
It is anticipated that the second Calgary licensed store will open the week of July 8. The location has been open since January 2019 to showcase the Fire & Flower retail experience including best-in-class cannabis education. Once cannabis products have been received, the location will offer a full assortment of cannabis products from licensed producers.
Organigram Holdings Inc. (TSXV: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., announced that it has now shipped its first cannabis products to the province of Quebec, following purchase orders placed with the Société québécoise du cannabis (SQDC) and following registration with the Autorité des Marchés Publics.
A true national player in Canada's legal adult use recreational cannabis marketplace, the Company has now distributed products for sale to all ten Canadian provinces.
"We are pleased to now officially ship our products coast to coast," says Greg Engel, CEO, Organigram. "Our national reach means brands such as Edison Cannabis Co. and Trailblazer are available across the country, offering a range of cannabis options for legal adult recreational cannabis consumers."
Organigram's currently available product portfolio includes value, mainstream and premium product offerings across the categories of dried flower, pre-rolls, and oils.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) announced its expansion into the global organic hemp CBD market with the launch of its Global Strategic Hemp Division. This new division will leverage TGOD's solid expertise in the European hemp CBD market to fuel growth and accelerate the development and commercialization of new products across its network of international partners.
"With the global CBD market expected to hit $22 billion in less than 3 years, it is clear that the segment is drawing substantial consumer demand," commented Brian Athaide, CEO of TGOD. "Our team has years of direct hands-on experience in the CBD space and we are excited to use this advantage to execute on a fast-moving market expansion strategy. CBD is a wellness product and has a natural fit with TGOD's certified organic positioning and the large segment of consumers who are increasingly demanding natural and organic products. The time to act is now, and TGOD has the team, the infrastructure and the capital to establish a significant presence in this market."
TGOD's acquisition of HemPoland in 2018 will continue to provide the Company with significant intellectual property and valuable insights as its Global Strategic Hemp Division expands into emerging hemp CBD markets. HemPoland saw its revenue for the first quarter grow by nearly 30% quarter over quarter as demand for high-quality hemp CBD products in Europe gains momentum.
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced that, at a special meeting of the Company's shareholders held earlier today, the Company's shareholders voted overwhelmingly in favour of the resolution approving the issuance of common shares of Canopy Growth and certain amendments to certain outstanding Company warrants in connection with the Company's previously announced proposed acquisition of Acreage Holdings, Inc..
The Canopy Shareholder Resolution was approved by approximately 99.05% of votes cast by disinterested Canopy Growth shareholders either in person or represented by proxy at the Meeting, in accordance with the requirements of the Toronto Stock Exchange. The report of voting results will be made available under Canopy Growth's profile on SEDAR at www.sedar.com.
In addition to the approval by Canopy Growth shareholders, Acreage shareholders approved the Transaction at a special meeting of shareholders held simultaneously today.
"On behalf of Canopy Growth, I thank the shareholders of both companies for their vote of confidence in this historic transaction," said Bruce Linton, Chairman & Co-CEO, Canopy Growth. "Completion of the Transaction is intended to position us to efficiently and effectively enter the US cannabis market once federally permissible. Alongside our international market strategies and US Hemp strategy, we believe the acquisition of Acreage will be a key step in bolstering our position as a truly global company."
Initial implementation of the Transaction is subject to approval by the Supreme Court of British Columbia and satisfaction of certain other closing conditions. Canopy Growth and Acreage expect the Transaction to be implemented on or about June 27, 2019. Completion of the Transaction is contingent on the occurrence or waiver, at Canopy Growth's discretion, of changes in US federal law to permit the general cultivation, distribution, and possession of cannabis or to remove the regulation of such activities from the federal Laws of the United States. Details of the payment will be included in a subsequent press release.
Boozer Inc. introduced Super Anytime Inc. , a wholly owned subsidiary of Boozer, and to announce Super has signed a Letter of Intent for a strategic partnership with Pineapple Express Delivery Inc. ("PED"). The Partnership will enable same-day, direct-to-consumer delivery of remote orders of recreational cannabis products from licensed retailers across Canada1 by leveraging Boozer's expertise in front-end consumer acquisition and mobile-app marketplaces, with PED's proven best-in-class last-mile delivery services. Canadians will soon be able to shop from multiple retailers via Super's unified e-commerce platform, with PED enabling integrated fulfillment and same-day delivery services.
Founded in 2017, Boozer is Canada's first mobile-app marketplace for compliant, on-demand, ordering of alcohol. Since inception, Boozer has developed a proven track record for accountability, compliance, and superior logistics, in a highly regulated industry with highly regulated products. Currently active in Toronto and Vancouver, Boozer seeks to consolidate the Canadian business-to-consumer alcohol market. Through Super, the Company is replicating its existing technology platform and capabilities to enter the emerging recreational cannabis market. Launching this year, Super seeks to make legal cannabis delivery a preferred option among consumers by presenting a convenient, safe, and enjoyable order and delivery experience, all in a manner that is compliant with provincial regulations.
PED is a leading Canadian cannabis delivery service and has been providing same-day delivery options to the legal Canadian cannabis market since October 2018. Boasting over 10 years experience providing on-demand last-mile delivery in various product categories, PED currently has a presence in many of Canada's largest markets, including Ontario, Manitoba, and Saskatchewan (Regina and Saskatoon), for both adult-use and medical deliveries (provincial regulations permitting).
"We're very excited to partner with the Super team and technology platform," said Randy Rolph, CEO of Pineapple Express Delivery. "Having observed the Boozer platform from afar, we were excited for the opportunity to partner with a group that has already achieved great success in generating orders of legal, government controlled substances that require compliant last-mile fulfillment services," he added.
Syqe Medical, a leading pharma-tech company, today announced the launch of the world's first pharmaceutical-grade metered-dose cannabis inhaler in Israel, empowering physicians to prescribe precise dosages meeting pharmaceutical standards. The debut of this drug delivery device reflects Syqe's mission to transform medical cannabis into a mainstream medical treatment.
This benchmark news is the culmination of eight years of research and development – including rigorous testing through multiple clinical trials – including four years of paving a novel regulatory path. The Syqe Inhaler and supporting clinical research is poised to unlock the global medical cannabis market by eliminating uncertainty surrounding dosage administration and alleviating physician concerns with regards to adverse events and psychoactivity. In turn, this will enable greater physician adoption of medical cannabis. Syqe's breakthrough drug delivery technology introduces complex respiration technique automation, electronic selective dosing and remote clinical monitoring and dose control, significantly expanding the applicability of this platform well beyond cannabis.
"80% of cannabis patients inhale the plant. For too long, physicians who wish to treat these patients have been without the most basic clinical knowledge on dosing, efficacy and adverse events of cannabis," says Perry Davidson, CEO and Founder of Syqe Medical. "For eight years Syqe has been developing proprietary technologies for the administration of raw plants, and through our clinical trials we were able to determine the recommended dosage of inhaled cannabis down to the microgram. This launch marks the beginning of a new chapter in pain treatment, one in which physicians can confidently prescribe precise dosages of cannabis, and patients can reap the rewards, effectively and responsibly."
The Syqe Inhaler, a non-combustion drug delivery device, has received the world's first ever regulatory approval from the Israeli Ministry of Health as a medical device combined with cannabis, and will be available for purchase by licensed patients in Israel.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
